IDXX
Price
$540.94
Change
+$0.30 (+0.06%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
44.84B
25 days until earnings call
XRAY
Price
$16.62
Change
+$0.05 (+0.30%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
6.69B
21 days until earnings call
Interact to see
Advertisement

IDXX vs XRAY

Header iconIDXX vs XRAY Comparison
Open Charts IDXX vs XRAYBanner chart's image
IDEXX Laboratories
Price$540.94
Change+$0.30 (+0.06%)
Volume$2.53K
Capitalization44.84B
DENTSPLY SIRONA
Price$16.62
Change+$0.05 (+0.30%)
Volume$61.98K
Capitalization6.69B
IDXX vs XRAY Comparison Chart in %
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. XRAY commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Buy and XRAY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (IDXX: $540.64 vs. XRAY: $16.57)
Brand notoriety: IDXX and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 81% vs. XRAY: 73%
Market capitalization -- IDXX: $44.84B vs. XRAY: $6.69B
IDXX [@Medical Specialties] is valued at $44.84B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 2 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • IDXX’s FA Score: 2 green, 3 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, IDXX is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 3 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).

  • IDXX’s TA Score: 3 bullish, 5 bearish.
  • XRAY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both IDXX and XRAY are a bad buy in the short-term.

Price Growth

IDXX (@Medical Specialties) experienced а -0.38% price change this week, while XRAY (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was +0.94%.

Reported Earning Dates

IDXX is expected to report earnings on Nov 04, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than XRAY($6.69B). IDXX has higher P/E ratio than XRAY: IDXX (52.87) vs XRAY (19.23). IDXX YTD gains are higher at: 30.766 vs. XRAY (-10.904). IDXX has higher annual earnings (EBITDA): 1.22B vs. XRAY (249M). IDXX has more cash in the bank: 454M vs. XRAY (334M). IDXX has less debt than XRAY: IDXX (1.07B) vs XRAY (2.3B). XRAY has higher revenues than IDXX: XRAY (3.97B) vs IDXX (3.66B).
IDXXXRAYIDXX / XRAY
Capitalization44.8B6.69B669%
EBITDA1.22B249M489%
Gain YTD30.766-10.904-282%
P/E Ratio52.8719.23275%
Revenue3.66B3.97B92%
Total Cash454M334M136%
Total Debt1.07B2.3B46%
FUNDAMENTALS RATINGS
IDXX vs XRAY: Fundamental Ratings
IDXX
XRAY
OUTLOOK RATING
1..100
2121
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
1796
PRICE GROWTH RATING
1..100
1356
P/E GROWTH RATING
1..100
4690
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (3) in the Medical Specialties industry is significantly better than the same rating for IDXX (87). This means that XRAY’s stock grew significantly faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that IDXX’s stock grew somewhat faster than XRAY’s over the last 12 months.

IDXX's SMR Rating (17) in the Medical Specialties industry is significantly better than the same rating for XRAY (96). This means that IDXX’s stock grew significantly faster than XRAY’s over the last 12 months.

IDXX's Price Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for XRAY (56). This means that IDXX’s stock grew somewhat faster than XRAY’s over the last 12 months.

IDXX's P/E Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for XRAY (90). This means that IDXX’s stock grew somewhat faster than XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXXRAY
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 8 days ago
68%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 28 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAFFX46.100.40
+0.88%
American Funds AMCAP R5
GCMTX35.66N/A
N/A
Goldman Sachs Mid Cap Value Inv
HCPCX53.85N/A
N/A
Hartford Capital Appreciation HLS IC
LRSOX20.87N/A
N/A
Lord Abbett Small Cap Value F3
BTEUX14.92N/A
N/A
Baron Technology R6

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+0.33%
A - IDXX
51%
Loosely correlated
+0.24%
RVTY - IDXX
51%
Loosely correlated
-0.53%
MTD - IDXX
50%
Loosely correlated
+1.00%
SYK - IDXX
49%
Loosely correlated
+0.65%
IQV - IDXX
48%
Loosely correlated
-1.49%
More